Takeda Announces New Assignments of Directors

June 27, 2017

Osaka, Japan, June 28, 2017 – Takeda Pharmaceutical Company Limited today announced new assignment of Directors. The details are as follows;

1. New assignment of Non-Audit and Supervisory Committee Directors effective June 28, 2017;

Name	Category	Role
Christophe Weber	Existing	Representative Director, President & Chief Executive Officer
Masato Iwasaki	Existing	Director, President, Japan Pharma Business Unit
James Kehoe	New	Director, Chief Financial Officer
Andrew Plump	Existing	Director, Chief Medical & Scientific Officer
Masahiro Sakane	Existing	External Director
Yoshiaki Fujimori	Existing	External Director
Emiko Higashi	Existing	External Director
Michel Orsinger	Existing	External Director
Toshiyuki Shiga	Existing	External Director

Masahiro Sakane, an External Director, will chair the board meeting.

2. Audit and Supervisory Committee Directors ;

Name	Role
Yasuhiko Yamanaka	Director, Audit & Supervisory Committee member
Shiro Kuniya	External Director, Chairperson of Audit & Supervisory Committee
Koji Hatsukawa	External Director, Audit & Supervisory Committee member
Jean-Luc Butel	External Director, Audit & Supervisory Committee member

Audit and Supervisory Committee Directors are within their 2-year tenure, and were not subjects for reelection this year.

3. New assignment of Non-Audit and Supervisory Committee Directors effective June 28, 2017;

- Compensation committee : Toshiyuki Shiga (Chair), Yoshiaki Fujimori, Yasuhiko Yamanaka

- Nomination committee : Masahiro Sakane (Chair), Emiko Higashi,

　　　　　　　　　　　　　　 Shiro Kuniya, Christophe Weber

Media Contact
Kazumi Kobayashi
Tel: +81-3-3278-2095
Email: [email protected]

###